Literature DB >> 22961067

Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.

HanJie Wang1, Wenya Su, Sheng Wang, Xiaomin Wang, Zhenyu Liao, Chunsheng Kang, Lei Han, Jin Chang, Guangxiu Wang, Peiyu Pu.   

Abstract

Glioblastoma with high mortality has been one of the most serious cancers threatening human health. Because of the present treatment limitations, there is an urgent need to construct a multifunctional vesicle for enhancing the treatment of in situ malignant glioblastoma. In our study, drug and gene co-loaded magnetic PLGA/multifunctional polymeric liposome (magnetic PLGA/MPLs) core-shell nanospheres were constructed. They were mainly self-assembled from two parts: hydrophobic PLGA cores that can load drugs and magnetic nanocrystals; and polymeric lipid shells anchored with functional molecules such as PEG chains, TAT peptides and RGD peptides that can help the vectors to condense the gene, prolong the circulation time, cross the blood brain barrier and target delivery to the cancer tissue. The results showed that the magnetic PLGA/MPLs nanosphere has a nanosized core-shell structure, can achieve sustained drug release and has good DNA binding abilities. Importantly, compared with the control group and other groups with single functionality, it can co-deliver the drug and gene into the same cell in vitro and show the strongest inhibiting effect on the growth of the in situ malignant glioblastoma in vivo. All of these results indicated that the different functional components of magnetic PLGA/MPLs, can form an organic whole and none of them can be dispensed with. The magnetic PLGA/MPLs nanosphere may be another option for treatment of glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961067     DOI: 10.1039/c2nr31263h

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  7 in total

Review 1.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function.

Authors:  Bharath Ramaswamy; Sandip D Kulkarni; Pablo S Villar; Richard S Smith; Christian Eberly; Ricardo C Araneda; Didier A Depireux; Benjamin Shapiro
Journal:  Nanomedicine       Date:  2015-06-24       Impact factor: 5.307

3.  Strategies in gene therapy for glioblastoma.

Authors:  Aneta Kwiatkowska; Mohan S Nandhu; Prajna Behera; E Antonio Chiocca; Mariano S Viapiano
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

Review 4.  Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.

Authors:  Amy Lee Bredlau; Suraj Dixit; Chao Chen; Ann-Marie Broome
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 5.  Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.

Authors:  Federico D'Agata; Federico Alessandro Ruffinatti; Silvia Boschi; Ilaria Stura; Innocenzo Rainero; Ornella Abollino; Roberta Cavalli; Caterina Guiot
Journal:  Molecules       Date:  2017-12-21       Impact factor: 4.411

6.  Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.

Authors:  Cem Varan; Erem Bilensoy
Journal:  Beilstein J Nanotechnol       Date:  2017-07-12       Impact factor: 3.649

Review 7.  Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.

Authors:  Yan Fang; Jianxiu Xue; Shan Gao; Anqi Lu; Dongjuan Yang; Hong Jiang; Yang He; Kai Shi
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.